1. Home
  2. FLXS vs ALLO Comparison

FLXS vs ALLO Comparison

Compare FLXS & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLXS
  • ALLO
  • Stock Information
  • Founded
  • FLXS 2001
  • ALLO 2017
  • Country
  • FLXS United States
  • ALLO United States
  • Employees
  • FLXS N/A
  • ALLO N/A
  • Industry
  • FLXS Home Furnishings
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FLXS Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • FLXS Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • FLXS 250.5M
  • ALLO 252.9M
  • IPO Year
  • FLXS N/A
  • ALLO 2018
  • Fundamental
  • Price
  • FLXS $34.59
  • ALLO $1.06
  • Analyst Decision
  • FLXS
  • ALLO Buy
  • Analyst Count
  • FLXS 0
  • ALLO 12
  • Target Price
  • FLXS N/A
  • ALLO $8.80
  • AVG Volume (30 Days)
  • FLXS 49.8K
  • ALLO 2.8M
  • Earning Date
  • FLXS 10-20-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • FLXS 2.31%
  • ALLO N/A
  • EPS Growth
  • FLXS 64.53
  • ALLO N/A
  • EPS
  • FLXS 4.11
  • ALLO N/A
  • Revenue
  • FLXS $447,505,000.00
  • ALLO N/A
  • Revenue This Year
  • FLXS $3.93
  • ALLO N/A
  • Revenue Next Year
  • FLXS $4.20
  • ALLO $100.00
  • P/E Ratio
  • FLXS $8.44
  • ALLO N/A
  • Revenue Growth
  • FLXS 6.00
  • ALLO N/A
  • 52 Week Low
  • FLXS $29.38
  • ALLO $0.86
  • 52 Week High
  • FLXS $65.87
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • FLXS 33.18
  • ALLO 35.63
  • Support Level
  • FLXS $34.00
  • ALLO $1.05
  • Resistance Level
  • FLXS $35.41
  • ALLO $1.28
  • Average True Range (ATR)
  • FLXS 1.84
  • ALLO 0.07
  • MACD
  • FLXS 0.01
  • ALLO -0.02
  • Stochastic Oscillator
  • FLXS 5.27
  • ALLO 5.37

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: